Shownotes
Medicare just finalized one of the most significant changes to 340B reimbursement in recent years. Beginning January 1, 2027, CMS will reduce reimbursement for most applicable 340B-acquired drugs from ASP +6% to ASP −28%—a 34-percentage-point reduction that could significantly impact hospital pharmacy margins.
In this episode of Revenue Rx, we break down the CY 2027 Hospital Outpatient Prospective Payment System (OPPS) Final Rule and what it means for hospital pharmacy leaders, 340B covered entities, and revenue cycle teams. From billions in redistributed outpatient payments to new JG, TB…

